Provided by Tiger Trade Technology Pte. Ltd.

Oculis

8.76
-0.5800-6.21%
Volume:414.99K
Turnover:3.69M
Market Cap:540.77M
PE:-5.11
High:9.26
Open:9.16
Low:8.70
Close:9.34
52wk High:34.48
52wk Low:8.70
Shares:61.73M
Float Shares:53.44M
Volume Ratio:1.79
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.05
PE(LYR):-3.67

Loading ...

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

GlobeNewswire
·
Jun 11

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jun 11

Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (AUTL), Galmed Pharmaceuticals (GLMD) and Oculis Holding (OCS)

TIPRANKS
·
Jun 11

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jun 10

Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease

GlobeNewswire
·
Jun 09

Oculis Stock Plummets After Phase 3 Trial Failures, Prompting Multiple Law Firm Probes

Deep News
·
Jun 09

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

GlobeNewswire
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA), Jade Biosciences (JBIO) and Oculis Holding (OCS)

TIPRANKS
·
Jun 06

Oculis Holding (OCS) Is Down 60.1% After OCS-01 Trial Failure And Pipeline Pivot – Has The Bull Case Changed?

Simply Wall St.
·
Jun 05

Oculis Holding Is Maintained at Overweight by JP Morgan

Dow Jones
·
Jun 04

Oculis price target lowered to $23 from $42 at JPMorgan

TIPRANKS
·
Jun 03

J.P. Morgan Reaffirms Their Buy Rating on Oculis Holding (OCS)

TIPRANKS
·
Jun 03

Oculis Holding Ag : JP Morgan Cuts Target Price to $23 From $42

THOMSON REUTERS
·
Jun 03

Eoptolink Technology Announces Comprehensive Positioning in Optical Circuit Switch Market

Deep News
·
Jun 02

Oculis Holding (OCS) Gets a Buy from Leerink Partners

TIPRANKS
·
Jun 02

Oculis Holding Is Maintained at Outperform by Baird

Dow Jones
·
Jun 02

Small U.S. Stocks Decrease; Oculis Holding Takes Biggest Hit

Dow Jones
·
Jun 02

Top Premarket Decliners

MT Newswires Live
·
Jun 01

Oculis Holding Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT), Oculis Holding (OCS) and Cogent Biosciences (COGT)

TIPRANKS
·
Jun 01